Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mycobacterial membrane transport and energy metabolism enzymes comprise a functional group of proteins essential for mycobacterial survival and pathogenesis. These include membrane-bound enzymes involved in oxidative phosphorylation (such as ATP synthase and NADH dehydrogenases), various classes of transporters responsible for importing nutrients and exporting toxins/drugs, and energy-coupling complexes required for adaptation to hypoxia and nutrient deprivation. Many, such as the ATP synthase and specific efflux or ABC transporters, are directly targeted by first- and second-line anti-tubercular drugs. Resistance mechanisms often involve mutations in these targets or upregulation of efflux systems. Due to their fundamental roles in energy generation, membrane integrity, and drug resistance, these enzymes collectively represent major therapeutic targets in mycobacterial infections (notably tuberculosis)[2][3][6][9]. However, the broad category term as presented does not correspond to a unique or standardized molecular entry, so specificity is needed for structure-function or drug development studies. For precise, structured records, specific targets within this group (e.g., ATP synthase subunit c, MmpL3 transporter, NADH dehydrogenase) should be referenced individually.
Inhibition of ATP synthase (leads to energy depletion of mycobacteria); Inhibition of electron transport chain complexes; Inhibition/blockade of membrane transporters, especially ABC and MFS types; Inhibition of efflux pumps to improve antibiotic potency.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mycobacterial membrane transporter and energy metabolism enzyme (null).